This content is machine translated Multiple sclerosis Treatment strategies, diagnostic modules and biomarkers in view The multifaceted pathogenesis of multiple sclerosis (MS) offers a variety of targets for therapeutic intervention. In addition, a lot of research is being done to be able to make the…
View Post 3 min This content is machine translated Neurological diseases Reduce disease burden, optimize therapies The theme of this year’s meeting of European neurologists was “Getting Evidence Into Practice.” Accordingly, the focus of the exchange was on ways to apply theoretical knowledge in practice. To…
View Post 3 min This content is machine translated Multiple sclerosis Effective therapy management also protects brain volume Each year, a person loses about 0.2-0.4% of their brain volume. So far, so normal. In patients with multiple sclerosis, however, this value is about twice as high. This is due…
View Post 3 min This content is machine translated "Medication Overuse Headache" (MOH). What does the updated S1 guideline say? The 2022 updated guideline incorporates the latest recommendations of the International Headache Society as well as current study findings on drug interventions. Antibodies directed against CGRP or its receptor have…
View Post 4 min This content is machine translated Amendment of the Swiss Narcotics Law Cannabis medicines now usable without exceptional approval Interest in the medicinal use of cannabinoids has increased greatly in recent years due to their wide range of applications and numerous reports of successful treatments. As of August 1,…
View Post 3 min This content is machine translated Therapy-refractory focal epilepsy New add-on antiepileptic drug significantly reduces seizure frequency For the treatment of focal epilepsy that cannot be adequately controlled despite previous therapy with at least two anticonvulsants, a new add-on therapy has recently become available for adults –…
View Post 3 min This content is machine translated Brain diseases Supply strategies discussed on an interdisciplinary basis Representatives from neurology, psychiatry and pharmacy met for the first time at the Berlin Brain Summit for an interdisciplinary summit on brain diseases. The aim of the inter-professional exchange was…
View Post 2 min This content is machine translated Mad Pride Mental health support On June 18, 2022, the Mad Pride took place in Bern. The aim was to raise awareness of the topic of “mental illness” and to break down prejudices. The federal government…
View Post 7 min This content is machine translated Headache Arriving at the diagnosis with “Red Flags Headache is the second most common cause of pain worldwide [1]. Three billion people are affected every year and often the diagnosis of the different types of headaches causes headaches…
View Post 5 min This content is machine translated Parkinson's therapy Studies on α-synuclein-binding antibodies disappointed Parkinson’s disease is a chronically progressive, neurodegenerative disease that, if left untreated, can quickly lead to a severely diminished quality of life due to its motor symptoms. Currently, there are…
View Post 4 min This content is machine translated No stent for stroke and intracranial stenosis? New data does not justify general exclusion TIA and stroke patients with advanced intracranial stenoses should generally not be stented – according to a 2016 G-BA decision. A recent randomized trial [1] shows: clinically stable patients do…
